Sept 2 (Reuters) - Ryvu Therapeutics:

* CONCLUSION OF STRATEGIC AGREEMENT WITH BIONTECH SE TO

SUPPORT

CLINICAL TRIALS FOR BIONTECH'S INVESTIGATIONAL CANCER

IMMUNOTHERAPIES IN POLAND

* TOTAL BUDGET FOR ORDERS TO RYVU AT 2.95 MILLION EUR

* AGREEMENT IS OF FRAMEWORK NATURE, AND INDIVIDUAL SERVICES

WILL

BE PERFORMED BY RYVU BASED ON INDEPENDENT ORDERS SUBMITTED BY

BIONTECH

* ORDERS SUPPORT BIONTECH IN ACTIVITIES AIMED AT

ACCELERATING

ACTIVATION OF CENTERS AND PATIENT RECRUITMENT FOR SEVERAL KEY

CLINICAL PROGRAMS IN FIELD OF ONCOLOGY, IMPLEMENTED BY BIONTECH

IN POLAND

* AGREEMENT EXPANDS EXISTING COLLABORATION WITH BIONTECH

Source text:

Further company coverage:

(Gdansk Newsroom)